ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study

NCT04051502 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Adnexal Mass

Interventions

DRUG: Method 1: Indocyanine green dye
DRUG: Method 2: Indocyanine green dye
DRUG: Method 3: Indocyanine green dye
DRUG: Method 3: Indocyanine green dye

Sponsor

Memorial Sloan Kettering Cancer Center